Table 1. Cancer Cell Line Response to Compound 1 in 7-Day Proliferation Assay (Supporting Information).
| cell line | histology | IC50 (μM) | max inhibition (%) |
|---|---|---|---|
| HCC1937 | breast | 0.030 | 83 |
| T-42D | breast | 0.003 | 84.0 |
| UACC-812 | breast | >2.5 | 21.0 |
| MX-1 cells | breast | >2.5 | 36.9 |
| NUGC-3 | gastric | 0.017 | 92 |
| KE-97 | gastric | 0.024 | 95.7 |
| MV4–11 | hematological | 0.016 | 93 |
| Daudi | hematological | 0.017 | 99.3 |
| Karpas-422 | hematological | 0.085 | 99.9 |
| HEL 92.1.7 | hematological | 0.003 | 91.2 |
| ARH-77 | hematological | 0.010 | 97.2 |
| REC-1 | hematological | 0.022 | 99.7 |
| IM-9 | hematological | 0.046 | 93 |
| KMS-12-BM | hematological | 0.006 | 99 |
| RPMI-8226 | hematological | 0.009 | 88.5 |
| OPM-2 | hematological | >2.5 | 22.5 |
| NCI-H2171 | lung | 0 010 | 97.7 |
| H-2122 | lung | 0.027 | 90 |
| NCI-H1930 | lung | >2.5 | 49.6 |
| NCI-H1651 | lung | >2.5 | 32 |
| A375 | skin | 0.037 | 91.1 |
| A2058 | skin | 0.013 | 96 |
| GAK | skin | 0.016 | 99.9 |
| Colo829 | skin | 0.013 | 51 |
| OVCAR-3 | ovarian | 0.032 | 95 |